Christoph Ruedig is a Partner at AlbionVC in London who co-leads the firm’s healthcare and life sciences. See portfolio, sector focus and contact routes.
Christoph Ruedig is a Partner at AlbionVC in London who co-leads the firm’s healthcare and life sciences investment team, having joined the firm in 2011 after working as a clinical radiologist, a Bain & Company strategy consultant, and an investor at 3i Group. He invests primarily in early-stage European startups across biotechnology, medical technology, telehealth, and digital health, with a specific focus on mission-driven founders aiming to fix broken healthcare systems. While specific check sizes and lead/follow behavior are not publicly detailed, he has participated in Series A and C rounds for ventures like Umedeor and Oviva. Notable portfolio companies include Oviva, a digital nutrition platform; uMotif, a clinical data collection tool; Umedeor, a healthtech startup; and Healios, a virtual mental health provider. Ruedig holds active board seats at Oviva, uMotif, Arecor, and Healios, reflecting his deep operational involvement. His distinctive point of view centers on leveraging his medical background to identify high-impact healthtech opportunities, and he has discussed his journey from radiology to healthtech investing in public podcasts.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in London.
Investors like Christoph Ruedig · Full investor directory · Investor access · Company funding database